Top Markets
#1 Islamic Coin Islamic Coin +155.93%
#2 Siren Siren +36.43%
#3 Arowana Arowana +20.52%
#4 OpenEden OpenEden +19.39%
#5 Nockchain Nockchain +18.27%
#6 Venom Venom +16.20%
#7 Cysic Cysic +15.89%
#8 KUB Coin KUB Coin +12.26%
#9 Perle Perle +11.45%
#10 RedStone RedStone +11.13%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rank in Stocks #31787
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Share Price
$0.21291741
Last synced: 2025-04-18
Market Cap
$12.07M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
KR
Trade PCL, Inc. (241820)

Category

Healthcare
Operating Margin for PCL, Inc. (241820)
Operating Margin as of August 2026 TTM: -80.52%
According to PCL, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -80.52%. At the end of 2023 the company had an Operating Margin of -191.37%.
Operating Margin history for PCL, Inc. from 2015 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -80.52% -96.30%
2024 -2,175.38% 1,036.74%
2023 -191.37% 757.78%
2022 -22.31% -60.04%
2021 -55.83% -234.53%
2020 41.50% -100.16%
2019 -26,678.73% 307.52%
2018 -6,546.68% 710.76%
2017 -807.47% 99.51%
2016 -404.72% -27.78%
2015 -560.40% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -100.21%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -100.27%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -100.22%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -100.27%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
28.09% -100.35%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.